Hoth Therapeutics Inc (NASDAQ: HOTH) Announce Positive Results From HT-003 Assets Group
Hoth Therapeutics Inc (NASDAQ: HOTH) announced that the HT-003 assets group had fetched positive results in the therapeutic model for Vivo acne. The model displayed HT-003’s capability in bringing down the expression for receptor 2 (TLR2), which is among the most significant pathways meant for acne pathophysiology. About the study results Additionally, the study underscored HT-003’s capability in bringing down the cytokines’ expression, which is helpful for acne pathophysiology. These…